查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太连续生物加工市场：按应用、最终用户、产品和国家分类的分析和预测（2023-2033）
市场调查报告书
商品编码
1546999

亚太连续生物加工市场：按应用、最终用户、产品和国家分类的分析和预测（2023-2033）

Asia-Pacific Continuous Bioprocessing Market: Focus on Application, End User, Product, and Country - Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 73 Pages | 商品交期: 1-5个工作天内

价格

亚太地区连续生物加工市场规模预计将从2023年的5,100万美元成长到2033年的3.885亿美元，预测期内复合年增长率为22.50%。

透过提高产量比率、灵活性、可製造性和产品一致性，同时降低製造成本来改善生物製药製造的需求不断增长，推动了市场的发展。为了获得一致的结果，生物加工最近已转向连续模式。

主要市场统计数据
预测期 2023-2033
2023年评估 5100万美元
2033年预测 3.885 亿美元
复合年增长率 22.5%

亚太地区的连续生物加工市场正在迅速扩大，在全球生物製药领域中发挥着举足轻重的作用。连续生物加工专注于提高生产力、适应性和产品质量，被认为是亚太地区生物製造转型的策略。许多好处，包括提高产量、降低製造成本以及生产可靠、高品质产品的能力，使该策略成为该地区运营的生物製药公司的理想选择。

该地区强大的生物製药製造基础设施和对新型治疗方法不断增长的需求正在推动该地区广泛采用连续上游生物加工。目前的重点是整合连续的下游生物製程、优化整体製程效率并进一步简化营运。这种整合预计将改变游戏规则，实现从开始到结束的无缝製造流程，减少停机时间，并提高生物製药製造的可扩展性。

该地区对研发的大量投资和政府的激励措施正在促进生物加工技术的持续发展。随着亚太地区生物製药市场的成长，连续生物加工的采用预计将加速，使该地区成为尖端生物製造技术的先驱。

市场分类

细分 1：依产品分类

  • 层析法系统/耗材
  • 过滤系统/设备
  • 反应器
  • 细胞培养基、细胞株、缓衝液、试剂
  • 其他的

细分2：依用途

  • 单株抗体
  • 疫苗
  • 细胞/基因治疗
  • 其他的

细分 3：依最终使用者分类

  • 製药和生物技术公司
  • 学术/研究机构
  • CRO

细分 4：按国家/地区划分

  • 日本
  • 印度
  • 中国
  • 韩国
  • 澳洲
  • 其他的

本报告调查了亚太地区连续生物加工市场，提供了行业趋势、技术和专利趋势、法律制度、市场增长促进和限制因素、市场规模趋势和预测、各个细分市场和主要领域的信息，总结详细的国家分析、竞争格局和主要企业概况。

目录

执行摘要

第一章 市场

  • 趋势：当前和未来的影响评估
    • 连续生物加工市场：趋势分析
    • 生物製药产业连续生物製程的数位化
    • 增加一次性生物製程设备的使用
  • 供应链概览
    • 价值链分析
  • 研发回顾
    • 专利申请趋势（按国家/年份）
  • 监管状况
  • 关键事件影响分析：COVID-19
  • 市场动态：概述
    • 市场驱动因素
    • 市场限制因素
    • 市场机会

第二章 区域

  • 区域概况
  • 亚太地区
    • 区域概况
    • 市场成长推进因素
    • 市场问题
    • 目的
    • 产品
    • 中国
    • 目的
    • 产品
    • 印度
    • 目的
    • 产品
    • 澳洲
    • 目的
    • 产品
    • 日本
    • 目的
    • 产品
    • 韩国
    • 目的
    • 产品
    • 其他的
    • 目的
    • 产品

第三章市场：竞争基准化分析与公司概况

  • 下一个前沿
  • 地理评估
    • OmniBRx Biotechnologies Pvt Ltd.

第四章调查方法

Product Code: BHL2280SS

Introduction to Asia-Pacific (APAC) Continuous Bioprocessing Market

The Asia-Pacific continuous bioprocessing market was valued at $51.0 million in 2023 and is expected to reach $388.5 million by 2033, growing at a CAGR of 22.50% between 2023 and 2033. Increased demand to improve biopharmaceutical production through increased yield, flexibility, productivity, and product consistency at the same time as lower manufacturing costs is driving the APAC market for continuous bioprocessing. In order to produce consistent results, bioprocessing has been moving toward continuous mode in recent years. The goal of ongoing efforts is to integrate downstream bioprocessing into a continuous operation, thereby increasing the efficiency and capabilities of the industry, even though continuous upstream bioprocessing has been established and widely adopted.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$51.0 Million
2033 Forecast$388.5 Million
CAGR22.5%

The Asia-Pacific continuous bioprocessing market is expanding quickly as the area assumes a pivotal role in the worldwide biopharmaceutical sector. As the emphasis on improving productivity, adaptability, and product quality grows, continuous bioprocessing is becoming recognized as a game-changing strategy for biomanufacturing in the Asia-Pacific region. Many benefits, such as increased yields, lower manufacturing costs, and the capacity to produce reliable, high-quality products, make this strategy a desirable one for biopharmaceutical companies operating in the area.

The region's strong biopharmaceutical manufacturing infrastructure and the rising demand for novel therapies have led to the widespread adoption of continuous upstream bioprocessing in APAC. The emphasis now is on integrating continuous downstream bioprocessing, optimizing overall process efficiency, and further streamlining operations. With seamless production flows from beginning to end, decreased downtime, and improved scalability of biopharmaceutical production, this integration is predicted to be a game-changer.

The continuous development of bioprocessing technologies is being fueled by the region's substantial investment in research and development as well as encouraging government initiatives. Continuous bioprocessing adoption is expected to pick up speed as the APAC biopharmaceutical market grows, establishing the region as a pioneer in cutting-edge biomanufacturing techniques.

Market Segmentation

Segmentation 1: by Product

  • Chromatography Systems and Consumables
  • Filtration Systems and Devices
  • Bioreactors
  • Cell Culture Media, Cell Lines, Buffers, and Reagents
  • Other Products

Segmentation 2: by Application

  • Monoclonal Antibodies
  • Vaccines
  • Cell and Gene Therapy
  • Other Applications

Segmentation 3: by End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations

Segmentation 4: by Country

  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific continuous bioprocessing market has been segmented based on application, end user, and product. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: In the continuous bioprocessing market, competitive strategy centers around innovation, collaboration, customization, and sustainability. Companies in the market strive to innovate by developing more efficient, scalable, and flexible bioprocessing technologies that reduce production times and costs while maintaining high product quality. Collaboration between equipment manufacturers, biopharmaceutical companies, and research institutions is crucial for sharing knowledge, optimizing processes, and accelerating the adoption of continuous bioprocessing.

Table of Contents

Executive Summary

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Continuous Bioprocessing Market Trend Analysis
    • 1.1.2 Digitization of Continuous Bioprocessing by the Biopharmaceutical Industry
    • 1.1.3 Increasing Use of Single-Use or Disposable Bioprocessing Equipment
  • 1.2 Supply Chain Overview
    • 1.2.1 Value Chain Analysis
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, by Year)
  • 1.4 Regulatory Landscape
  • 1.5 Impact Analysis for Key Events: COVID-19
  • 1.6 Market Dynamics Overview
    • 1.6.1 Market Drivers
      • 1.6.1.1 Growing Demand for Continuous Bioprocessing due to the Flourishing Biopharmaceutical Sector
      • 1.6.1.2 Cost Reduction with Continuous Bioprocessing as Compared to Batch and Fed-Batch Bioprocessing
      • 1.6.1.3 Increasing Adoption of New Technologies like Single-Use Bioprocessing Technology
    • 1.6.2 Market Restraints
      • 1.6.2.1 Technological Complexities and Operational Challenges
      • 1.6.2.2 High Initial Cost Associated with Continuous Bioprocessing
    • 1.6.3 Market Opportunities
      • 1.6.3.1 Numerous Proposed Technologies in Continuous Bioprocessing
      • 1.6.3.2 Moving Closer to End-to-End Continuous Bioprocessing

2 Region

  • 2.1 Regional Summary
  • 2.2 Asia-Pacific
    • 2.2.1 Regional Overview
    • 2.2.2 Driving Factors for Market Growth
    • 2.2.3 Factors Challenging the Market
    • 2.2.4 Application
    • 2.2.5 Product
    • 2.2.6 China
    • 2.2.7 Application
    • 2.2.8 Product
    • 2.2.9 India
    • 2.2.10 Application
    • 2.2.11 Product
    • 2.2.12 Australia
    • 2.2.13 Application
    • 2.2.14 Product
    • 2.2.15 Japan
    • 2.2.16 Application
    • 2.2.17 Product
    • 2.2.18 South Korea
    • 2.2.19 Application
    • 2.2.20 Product
    • 2.2.21 Rest-of-Asia-Pacific
    • 2.2.22 Application
    • 2.2.23 Product

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Next Frontiers
  • 3.2 Geographic Assessment
    • 3.2.1 OmniBRx Biotechnologies Pvt Ltd.
      • 3.2.1.1 Overview
      • 3.2.1.2 Top Products/Product Portfolio
      • 3.2.1.3 Top Competitors
      • 3.2.1.4 Target Customers
      • 3.2.1.5 Key Personnel
      • 3.2.1.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-Pacific Continuous Bioprocessing Market, $Million, 2023, 2026, and 2033
  • Figure 2: Asia-Pacific Continuous Bioprocessing Market (by Application), $Million, 2022, 2026, and 2033
  • Figure 3: Asia-Pacific Continuous Bioprocessing Market (by Product), $Million, 2022, 2026, and 2033
  • Figure 4: Asia-Pacific Continuous Bioprocessing Market (by End User), $Million, 2022, 2026, and 2033
  • Figure 5: Evolution of Single-Use Facilities, 2019-2022
  • Figure 6: Supply Chain and Identifying Risks within the Supply Chain
  • Figure 7: Continuous Bioprocessing Market (by Country), January 2020-December 2023
  • Figure 8: Continuous Bioprocessing Market (by Year), January 2020-December 2023
  • Figure 9: Long-Term Effect of COVID-19 on Bioprocessing, Biopharma Vs Suppliers
  • Figure 10: Impact of COVID-19 on the Continuous Bioprocessing Market, Pre, During, and Post-COVID-19 Scenario
  • Figure 11: Impact Analysis of Market Navigating Factors, 2023-2033
  • Figure 12: Growth of Biopharmaceutical Research and Development, 2012-2022, $ Million
  • Figure 13: Comparison of Processes and Facilities for Different Batch Types
  • Figure 14: Cost Comparison: Continuous vs. Batch and Fed-Batch Bioprocessing, $ Million
  • Figure 15: Respondents Using Single-Use Bioprocessing Technology, All Scales (R&D to Commercial), 2018-2022, %
  • Figure 16: Novel Bioprocessing Systems/Innovations Evaluated in 12 Months, 2021
  • Figure 17: Factors Contributing to High Initial Costs in Continuous Bioprocessing Facilities
  • Figure 18: Proposed Technologies in Continuous Biopharmaceutical Manufacturing
  • Figure 19: Developments in Continuous Bioprocessing Generating Need for End-to-End Continuous Bioprocessing Facilities
  • Figure 20: China Continuous Bioprocessing Market, $Million, 2022-2033
  • Figure 21: India Continuous Bioprocessing Market, $Million, 2022-2033
  • Figure 22: Australia Continuous Bioprocessing Market, $Million, 2022-2033
  • Figure 23: Japan Continuous Bioprocessing Market, $Million, 2022-2033
  • Figure 24: South Korea Continuous Bioprocessing Market, $Million, 2022-2033
  • Figure 25: Rest-of-Asia-Pacific Continuous Bioprocessing Market, $Million, 2022-2033
  • Figure 26: Strategic Initiatives, 2020-2023
  • Figure 27: Share of Strategic Initiatives, 2020-2023
  • Figure 28: Data Triangulation
  • Figure 29: Top-Down and Bottom-Up Approach
  • Figure 30: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Continuous Bioprocessing Market, Opportunities
  • Table 3: Product Portfolio Company Positioning
  • Table 4: Example of Digitization of Continuous Bioprocessing
  • Table 5: Survey on Industry Perceptions of Continuous Bioprocessing Vs Batch-Fed Processing (N=140+ Biopharmaceutical Companies)
  • Table 6: Continuous Bioprocessing Market (by Region), $Million, 2022-2033
  • Table 7: Asia-Pacific Continuous Bioprocessing Market (by Application), $Million, 2022-2033
  • Table 8: Asia-Pacific Continuous Bioprocessing Market (by End User), $Million, 2022-2033
  • Table 9: Asia-Pacific Continuous Bioprocessing Market (by Product), $Million, 2022-2033
  • Table 10: China Continuous Bioprocessing Market (by Application), $Million, 2022-2033
  • Table 11: China Continuous Bioprocessing Market (by End User), $Million, 2022-2033
  • Table 12: China Continuous Bioprocessing Market (by Product), $Million, 2022-2033
  • Table 13: India Continuous Bioprocessing Market (by Application), $Million, 2022-2033
  • Table 14: India Continuous Bioprocessing Market (by End User), $Million, 2022-2033
  • Table 15: India Continuous Bioprocessing Market (by Product), $Million, 2022-2033
  • Table 16: Australia Continuous Bioprocessing Market (by Application), $Million, 2022-2033
  • Table 17: Australia Continuous Bioprocessing Market (by End User), $Million, 2022-2033
  • Table 18: Australia Continuous Bioprocessing Market (by Product), $Million, 2022-2033
  • Table 19: Japan Continuous Bioprocessing Market (by Application), $Million, 2022-2033
  • Table 20: Japan Continuous Bioprocessing Market (by End User), $Million, 2022-2033
  • Table 21: Japan Continuous Bioprocessing Market (by Product), $Million, 2022-2033
  • Table 22: South Korea Continuous Bioprocessing Market (by Application), $Million, 2022-2033
  • Table 23: South Korea Continuous Bioprocessing Market (by End User), $Million, 2022-2033
  • Table 24: South Korea Continuous Bioprocessing Market (by Product), $Million, 2022-2033
  • Table 25: Rest-of-Asia-Pacific Continuous Bioprocessing Market (by Application), $Million, 2022-2033
  • Table 26: Rest-of-Asia-Pacific Continuous Bioprocessing Market (by End User), $Million, 2022-2033
  • Table 27: Rest-of-Asia-Pacific Continuous Bioprocessing Market (by Product), $Million, 2022-2033